Fox Run Management’s Eli Lilly LLY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$873K Buy
+985
New +$999K 0.15% 224
2025
Q3
Sell
-1,514
Closed -$1.18M 1097
2025
Q2
$1.18M Buy
+1,514
New +$1.18M 0.2% 140
2024
Q4
Sell
-692
Closed -$613K 1040
2024
Q3
$613K Buy
+692
New +$622K 0.14% 276
2023
Q2
Sell
-1,529
Closed -$525K 842
2023
Q1
$525K Buy
+1,529
New +$516K 0.17% 209
2022
Q2
Sell
-1,522
Closed -$436K 651
2022
Q1
$436K Sell
1,522
-102
-6% -$26.3K 0.24% 137
2021
Q4
$449K Buy
+1,624
New +$412K 0.26% 102
2020
Q2
Sell
-1,691
Closed -$235K 294
2020
Q1
$235K Buy
+1,691
New +$232K 0.56% 60
2018
Q4
Sell
-6,526
Closed -$700K 629
2018
Q3
$700K Buy
+6,526
New +$652K 0.31% 66
2018
Q2
Sell
-2,774
Closed -$215K 808
2018
Q1
$215K Sell
2,774
-344
-11% -$27.7K 0.05% 605
2017
Q4
$263K Sell
3,118
-682
-18% -$58K 0.08% 501
2017
Q3
$325K Buy
+3,800
New +$312K 0.09% 456
2017
Q2
Sell
-5,300
Closed -$446K 729
2017
Q1
$446K Buy
+5,300
New +$425K 0.18% 226
2016
Q4
Sell
-4,500
Closed -$361K 598
2016
Q3
$361K Buy
4,500
+1,100
+32% +$88K 0.21% 194
2016
Q2
$268K Buy
+3,400
New +$256K 0.13% 334

Other funds holding LLY

Fox Run Management's LLY Position: Q1 2026 in Review

Fox Run Management opened a new position in Eli Lilly (LLY) in Q1 2026: 985 shares worth $873K. The stake represents 0.15% of the portfolio and ranks #224 among its holdings. This is a return to the name: Fox Run Management previously reported a position in LLY as recently as Q2 2025.

Fox Run Management first reported a position in LLY in Q2 2016 and has held it in 14 quarters since. The position peaked at $1.18M in Q2 2025. 4,354 funds tracked by Wall St. Rank hold LLY as of Q1 2026.

  • Fox Run Management held 985 shares of Eli Lilly worth $873K as of Q1 2026.
  • Eli Lilly was a new Fox Run Management position in Q1 2026.
  • Eli Lilly made up 0.15% of Fox Run Management's portfolio in Q1 2026, its #224 holding.
  • Fox Run Management first reported a position in Eli Lilly in Q2 2016 and has held it in 14 quarters since.
  • Fox Run Management's Eli Lilly position peaked at $1.18M in Q2 2025.
  • 4,354 funds tracked by Wall St. Rank held Eli Lilly as of Q1 2026.

Based on Fox Run Management's 13F filing for Q1 2026, filed 12 May 2026.